Article
Can Proopiomelanocortin Methylation Be Used as an Early Predictor of Metabolic Syndrome?
13 Nov 2013
Abstract excerpt
OBJECTIVE: The objectives of this study were to compare early predictive marker of the metabolic syndrome with proopiomelanocortin (POMC) methylation status and to determine the association among birth weight, ponderal index, and cord blood methylation status. RESEARCH DESIGN AND METHODS: We collected pregnancy outcome data from pregnant women, cord blood samples at delivery, and blood from children (7-9 years...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
